Eva Renee Barnett, Chief Financial Officer at Immunovant, Inc. (IMVT), sold 6,196 shares at $41.64 ($259K) on 2024-01-11, disclosed to the SEC on 2024-01-12.
Open-market sale of $259k IMVT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.64 | 2,681 | $112K | 43.2% |
| 2 | $41.64 | 2,681 | $112K | 43.2% |
| 3 | $42.43 | 834 | $35K | 13.7% |
| Total | $41.75 avg | 6,196 | $259K | 100% |
| Filing → |
| IMVT | SELL | 2025-02-21 | $117K | — | Filing → |
| IMVT | SELL | 2025-01-17 | $107K | — | Filing → |
| IMVT | SELL | 2025-01-10 | $198K | — | Filing → |